Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/02/2012EP2447268A1 Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
05/02/2012EP2447266A1 Pyrimidopyridine compound used as a CSBP/RK/p38 modulator
05/02/2012EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same
05/02/2012EP2447264A1 N-substituted-cyclic amino derivative
05/02/2012EP2447263A1 Benzazole derivatives as histamine H4 receptor ligands
05/02/2012EP2447258A1 Dioxanes derived from regrouping carbohydrates and c-glycosides, method for obtaining same, and uses thereof
05/02/2012EP2447257A1 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis
05/02/2012EP2447254A1 Crystals
05/02/2012EP2447253A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
05/02/2012EP2447251A1 N-(1-phenyl-2-oxo-3-piperidyl sulphonamide libraries for drug discovery
05/02/2012EP2447249A1 N-phenyl-1-sulfonyl-2-pyrrolidine carboxamide libraries for drug discovery
05/02/2012EP2447248A2 Modified chalcone compounds as antimitotic agents
05/02/2012EP2446903A2 Methods, compositions, and kits for treating pain and pruritis
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446891A1 Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446889A1 Difructose anhydride-containing composition for use in improving bowel movement
05/02/2012EP2446888A2 Use of danazol for the treatment of uveitis
05/02/2012EP2446887A2 Use of danazol for the treatment of Alzheimer's disease
05/02/2012EP2446886A1 Autophagy regulators and the uses thereof in the treatment of collagen VI defective Muscular Dystrophies
05/02/2012EP2446885A1 Therapeutic agent for hypertension or normal high blood pressure
05/02/2012EP2446884A1 Composition for inhibiting inflammation comprising hyaluronic acid and a hmg-coa reductase inhibitor
05/02/2012EP2446883A1 Treatment of inflammation
05/02/2012EP2446882A1 Medicament with improved storage stability containing the active ingredient hydromorphone
05/02/2012EP2446881A1 Orally Dissolving Films
05/02/2012EP2446879A2 Pharmaceutical composition containing carboxylosartan and a production method therefor
05/02/2012EP2446878A1 Ketorolac tromethamine compositions for treating or preventing ocular pain
05/02/2012EP2446754A1 Fermentation product of a cereal-derived material and immunomodulator
05/02/2012EP2446037A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
05/02/2012EP2446036A2 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
05/02/2012EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof
05/02/2012EP2445922A2 Hybrid molecules made of lipids and lipid-analogous compounds and use thereof as pharmaceutical or cosmetic preparation
05/02/2012EP2445916A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
05/02/2012EP2445915A1 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
05/02/2012EP2445914A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
05/02/2012EP2445913A1 Tricyclic pyrimidine derivatives as wnt antagonists
05/02/2012EP2445912A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
05/02/2012EP2445911A1 5-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
05/02/2012EP2445910A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
05/02/2012EP2445909A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
05/02/2012EP2445908A1 Disubstituted benzamide derivatives as glucokinase (gk) activators
05/02/2012EP2445904A1 Novel gpr 119 agonists
05/02/2012EP2445903A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
05/02/2012EP2445901A1 New compounds, pharmaceutical composition and methods relating thereto
05/02/2012EP2445900A2 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
05/02/2012EP2445899A1 Novel fumarate salts of a histamine h3 receptor antagonist
05/02/2012EP2445898A2 4h-pyrido[1,2-a]pyrimidin-4-one derivatives as pi3k inhibitors
05/02/2012EP2445897A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
05/02/2012EP2445895A2 Piperazine dithioctate and pharmaceutical composition comprising the same
05/02/2012EP2445892A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445891A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445889A1 Novel oxazolone and pyrrolidinone-substituted arylamides
05/02/2012EP2445887A2 Novel azabicyclohexanes
05/02/2012EP2445886A1 Heterocyclic compounds and their uses
05/02/2012EP2445885A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
05/02/2012EP2445883A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
05/02/2012EP2445878A1 New compounds, pharmaceutical composition and methods relating thereto
05/02/2012EP2445877A2 Bicyclic compounds and methods of making and using same
05/02/2012EP2445876A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
05/02/2012EP2445875A2 Heterocyclic antiviral compound
05/02/2012EP2445873A2 Protease inhibitors, compositions and methods of use
05/02/2012EP2445872A1 Cathepsin cysteine protease inhibitors for the treatment of various diseases
05/02/2012EP2445868A2 Novel biphenyl and phenyl-pyridine amides
05/02/2012EP2445867A2 Ceramide dimers and the use thereof as pharmaceutical products or cosmetic preparation
05/02/2012EP2445861A1 Novel acetylsalicylic acid salts
05/02/2012EP2445859A2 Method for isolating cimiracemate a
05/02/2012EP2445588A2 Topical formulation containing a tetracycline and a method of treating skin infections using the same
05/02/2012EP2445571A1 Solid drug tablets for implantable drug delivery devices
05/02/2012EP2445570A1 Implantable drug delivery devices and methods of making the same
05/02/2012EP2445533A1 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/02/2012EP2445529A2 Marker differentially expressed in cancer stem cells and methods of using same
05/02/2012EP2445519A1 Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
05/02/2012EP2445508A1 Nitric oxide therapies
05/02/2012EP2445507A1 Cross-linked polyallylamine tablet core
05/02/2012EP2445506A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
05/02/2012EP2445505A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
05/02/2012EP2445504A1 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
05/02/2012EP2445503A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
05/02/2012EP2445502A1 Heterocyclic compounds for the treatment of neurological and psychological disorders
05/02/2012EP2445501A2 Use of quingolide in the treatment of endometriosis, pain and cancer
05/02/2012EP2445500A1 Combination treatment op a g2 checkpoint inhibitor (sb-218078) and a chemotherapeutic agent for tumorigenic cells in solid tumors
05/02/2012EP2445499A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
05/02/2012EP2445498A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
05/02/2012EP2445497A2 Use of derivatives of indoles for the treatment of cancer
05/02/2012EP2445496A2 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
05/02/2012EP2445495A1 Composition for treatment of tuberculosis
05/02/2012EP2445494A1 Treatment of insulin resistance and obesity by stimulating glp-1 release
05/02/2012EP2445493A1 Topical composition containing naproxen
05/02/2012EP2445492A1 Topical composition containing ibuprofen
05/02/2012EP2445491A1 Pharmaceutical composition for emergency contraception
05/02/2012EP2445490A2 Methods for treating or preventing fatigue
05/02/2012EP2445489A2 Compositions for treating drug addiction and improving addiction-related behavior
05/02/2012EP2445488A1 Process for obtaining purified pterostilbene and methods of use thereof
05/02/2012EP2445486A2 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
05/02/2012EP2445484A1 Aprepitant in the form of a solid solution
05/02/2012EP2445483A2 Topical compositions and methods for wound care
05/02/2012EP2445371A1 Applicator for applying a product to hair
05/02/2012EP2445350A1 Methods and products for treatment of diseases
1 ... 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 ... 7860